Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Edwards Lifesciences

EW Clue Score50
United States Fiscal year ends December CIK 0001099800
85.21
+1.15%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
85.21 on 9 Oct 2026
95 84 73 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $72.95 14 Oct 2025 $73.36 15 Oct 2025 $72.93 16 Oct 2025 $72.65 17 Oct 2025 $74.64 20 Oct 2025 $75.29 21 Oct 2025 $76.02 22 Oct 2025 $76.84 23 Oct 2025 $76.53 24 Oct 2025 $76.10 27 Oct 2025 $80.82 28 Oct 2025 $82.19 29 Oct 2025 $82.69 30 Oct 2025 $83.48 31 Oct 2025 $82.45 3 Nov 2025 $83.07 4 Nov 2025 $84.15 5 Nov 2025 $82.84 6 Nov 2025 $82.44 7 Nov 2025 $83.39 10 Nov 2025 $84.08 11 Nov 2025 $85.16 12 Nov 2025 $85.58 13 Nov 2025 $86.11 14 Nov 2025 $86.30 17 Nov 2025 $84.74 18 Nov 2025 $84.04 19 Nov 2025 $86.02 20 Nov 2025 $84.09 21 Nov 2025 $85.13 24 Nov 2025 $84.71 25 Nov 2025 $86.82 26 Nov 2025 $86.75 28 Nov 2025 $86.67 1 Dec 2025 $85.27 2 Dec 2025 $84.71 3 Dec 2025 $83.98 4 Dec 2025 $85.78 5 Dec 2025 $86.19 8 Dec 2025 $84.32 9 Dec 2025 $83.28 10 Dec 2025 $83.92 11 Dec 2025 $84.24 12 Dec 2025 $83.08 15 Dec 2025 $83.38 16 Dec 2025 $85.32 17 Dec 2025 $84.84 18 Dec 2025 $84.80 19 Dec 2025 $85.66 22 Dec 2025 $86.53 23 Dec 2025 $86.23 24 Dec 2025 $86.29 26 Dec 2025 $86.85 29 Dec 2025 $86.94 30 Dec 2025 $86.20 31 Dec 2025 $85.25 2 Jan 2026 $85.33 5 Jan 2026 $84.17 6 Jan 2026 $85.85 7 Jan 2026 $84.83 8 Jan 2026 $84.58 9 Jan 2026 $85.13 12 Jan 2026 $83.01 13 Jan 2026 $83.84 14 Jan 2026 $83.10 15 Jan 2026 $84.49 16 Jan 2026 $84.35 20 Jan 2026 $83.46 21 Jan 2026 $85.14 22 Jan 2026 $84.44 23 Jan 2026 $83.66 26 Jan 2026 $84.27 27 Jan 2026 $83.60 28 Jan 2026 $81.86 29 Jan 2026 $81.49 30 Jan 2026 $81.36 2 Feb 2026 $82.65 3 Feb 2026 $82.10 4 Feb 2026 $79.77 5 Feb 2026 $78.10 6 Feb 2026 $78.71 9 Feb 2026 $76.80 10 Feb 2026 $77.05 11 Feb 2026 $79.33 12 Feb 2026 $76.44 13 Feb 2026 $75.87 17 Feb 2026 $78.45 18 Feb 2026 $78.98 19 Feb 2026 $78.92 20 Feb 2026 $79.78 23 Feb 2026 $82.44 24 Feb 2026 $82.40 25 Feb 2026 $83.40 26 Feb 2026 $85.90 27 Feb 2026 $86.47 2 Mar 2026 $87.18 3 Mar 2026 $85.28 4 Mar 2026 $85.22 5 Mar 2026 $83.89 6 Mar 2026 $81.64 9 Mar 2026 $84.26 10 Mar 2026 $85.78 11 Mar 2026 $85.09 12 Mar 2026 $84.61 13 Mar 2026 $81.81 16 Mar 2026 $83.56 17 Mar 2026 $84.27 18 Mar 2026 $82.61 19 Mar 2026 $82.46 20 Mar 2026 $82.50 23 Mar 2026 $82.02 24 Mar 2026 $81.69 25 Mar 2026 $82.67 26 Mar 2026 $82.10 27 Mar 2026 $79.34 30 Mar 2026 $79.50 31 Mar 2026 $80.08 1 Apr 2026 $81.26 2 Apr 2026 $81.05 6 Apr 2026 $81.19 7 Apr 2026 $80.84 8 Apr 2026 $81.71 9 Apr 2026 $79.15 10 Apr 2026 $77.87 13 Apr 2026 $78.12 14 Apr 2026 $78.20 15 Apr 2026 $78.20 16 Apr 2026 $79.05 17 Apr 2026 $80.99 20 Apr 2026 $81.44 21 Apr 2026 $79.71 22 Apr 2026 $81.53 23 Apr 2026 $79.72 24 Apr 2026 $84.15 27 Apr 2026 $83.46 28 Apr 2026 $82.28 29 Apr 2026 $81.22 30 Apr 2026 $83.50 1 May 2026 $83.98 4 May 2026 $83.33 5 May 2026 $82.91 6 May 2026 $83.20 7 May 2026 $82.76 8 May 2026 $79.96 11 May 2026 $77.17 12 May 2026 $79.73 13 May 2026 $81.39 14 May 2026 $81.34 15 May 2026 $81.38 18 May 2026 $82.39 19 May 2026 $82.16 20 May 2026 $82.97 21 May 2026 $83.20 22 May 2026 $85.78 26 May 2026 $87.54 27 May 2026 $86.51 28 May 2026 $85.96 29 May 2026 $86.47 1 Jun 2026 $88.16 2 Jun 2026 $87.66 3 Jun 2026 $86.00 4 Jun 2026 $87.45 5 Jun 2026 $85.96 8 Jun 2026 $85.85 9 Jun 2026 $87.54 10 Jun 2026 $85.98 11 Jun 2026 $85.76 12 Jun 2026 $85.11 15 Jun 2026 $86.28 16 Jun 2026 $88.58 17 Jun 2026 $86.68 18 Jun 2026 $87.36 22 Jun 2026 $85.88 23 Jun 2026 $86.95 24 Jun 2026 $89.66 25 Jun 2026 $89.72 26 Jun 2026 $90.78 29 Jun 2026 $91.18 30 Jun 2026 $90.46 1 Jul 2026 $91.99 2 Jul 2026 $94.37 6 Jul 2026 $95.18 7 Jul 2026 $94.82 8 Jul 2026 $93.64 9 Jul 2026 $91.33 10 Jul 2026 $92.21 13 Jul 2026 $91.79 14 Jul 2026 $90.09 15 Jul 2026 $87.27 16 Jul 2026 $87.84 17 Jul 2026 $85.73 20 Jul 2026 $85.00 21 Jul 2026 $84.55 22 Jul 2026 $84.37 23 Jul 2026 $83.82 24 Jul 2026 $82.63 27 Jul 2026 $83.04 28 Jul 2026 $83.68 29 Jul 2026 $85.76 30 Jul 2026 $86.92 31 Jul 2026 $86.07 3 Aug 2026 $88.82 4 Aug 2026 $89.60 5 Aug 2026 $88.97 6 Aug 2026 $89.32 7 Aug 2026 $89.72 10 Aug 2026 $92.03 11 Aug 2026 $93.66 12 Aug 2026 $93.05 13 Aug 2026 $92.56 14 Aug 2026 $91.60 17 Aug 2026 $90.81 18 Aug 2026 $90.98 19 Aug 2026 $92.28 20 Aug 2026 $89.83 21 Aug 2026 $89.79 24 Aug 2026 $90.50 25 Aug 2026 $90.87 26 Aug 2026 $90.78 27 Aug 2026 $89.95 28 Aug 2026 $90.21 31 Aug 2026 $90.75 1 Sep 2026 $90.74 2 Sep 2026 $90.82 3 Sep 2026 $89.78 4 Sep 2026 $89.90 8 Sep 2026 $86.72 9 Sep 2026 $86.18 10 Sep 2026 $86.77 11 Sep 2026 $84.37 14 Sep 2026 $85.52 15 Sep 2026 $85.74 16 Sep 2026 $89.28 17 Sep 2026 $88.25 18 Sep 2026 $88.26 21 Sep 2026 $88.34 22 Sep 2026 $88.78 23 Sep 2026 $86.82 24 Sep 2026 $85.73 25 Sep 2026 $86.29 28 Sep 2026 $86.83 29 Sep 2026 $88.08 30 Sep 2026 $86.32 1 Oct 2026 $85.19 2 Oct 2026 $85.15 5 Oct 2026 $87.23 6 Oct 2026 $86.48 7 Oct 2026 $85.78 8 Oct 2026 $84.24 9 Oct 2026 $85.21 Lippis Daniel J. CVP, JAPAC Sold on a plan $84.20K 10 Nov 2025 · at $82.55 · 4.4% of stake Ullem Scott B. CVP, Chief Financial Officer Sold on a plan $1.08M 10 Nov 2025 · at $83.08 · 24.6% of stake Markowitz Wayne CVP, JAPAC Sold at will $50.14K 8 Dec 2025 · at $86.01 · 3.2% of stake Zovighian Bernard J CEO Sold on a plan $1.83M 8 Dec 2025 · at $85.21 · 20.2% of stake Ullem Scott B. CVP, Chief Financial Officer Sold on a plan $650.41K 9 Dec 2025 · at $84.47 · 16.2% of stake Zovighian Bernard J CEO Sold on a plan $322.37K 10 Dec 2025 · at $83.45 · 31.0% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold on a plan $950.58K 10 Dec 2025 · at $83.83 · 18.4% of stake Chopra Daveen CVP, TMTT & Surgical Sold at will $168.75K 11 Dec 2025 · at $84.38 · 5.8% of stake Lippis Daniel J. CVP, JAPAC Sold on a plan $85.63K 12 Dec 2025 · at $84.03 · 4.4% of stake STONE HEISZ LESLIE Director Sold at will $218.12K 12 Dec 2025 · at $83.41 · 7.8% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold at will $953.75K 12 Dec 2025 · at $83.76 · 22.6% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold on a plan $971.43K 6 Jan 2026 · at $85.66 · 26.2% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $87.33K 9 Jan 2026 · at $85.70 · 4.4% of stake Zovighian Bernard J CEO Sold at will $1.72M 12 Feb 2026 · at $76.67 · 21.1% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold at will $2.01M 25 Feb 2026 · at $83.84 · 53.0% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold on a plan $974.43K 2 Mar 2026 · at $85.93 · 34.8% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $87.00K 11 Mar 2026 · at $85.38 · 2.9% of stake Ullem Scott B. CVP, Chief Financial Officer Sold on a plan $1.10M 11 Mar 2026 · at $84.92 · 24.7% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold on a plan $1.82M 2 Apr 2026 · at $80.16 · 51.6% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $82.52K 6 Apr 2026 · at $80.98 · 2.9% of stake Ullem Scott B. CVP, Chief Financial Officer Sold on a plan $1.04M 9 Apr 2026 · at $80.04 · 24.7% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $84.58K 1 May 2026 · at $83.01 · 2.9% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $85.58K 4 May 2026 · at $83.98 · 2.9% of stake Markowitz Wayne CVP, JAPAC Sold at will $47.28K 11 May 2026 · at $79.73 · 2.7% of stake Zovighian Bernard J CEO Sold on a plan $2.83M 12 May 2026 · at $77.93 · 75.1% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold at will $654.57K 15 May 2026 · at $81.82 · 20.5% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold at will $818.11K 15 May 2026 · at $82.07 · 30.4% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $50.31K 18 May 2026 · at $81.14 · 1.5% of stake Chopra Daveen CVP, TMTT & Surgical Sold at will $126.91K 22 May 2026 · at $84.60 · 3.3% of stake BOBO DONALD E JR CVP,Strategy/Corp Development Sold at will $2.00M 27 May 2026 · at $86.42 · 19.0% of stake Dahl Andrew M. SVP, Corporate Controller Sold at will $48.85K 29 May 2026 · at $86.08 · 3.6% of stake Zovighian Bernard J CEO Sold on a plan $45.98K 17 Jun 2026 · at $87.92 · 4.3% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $56.58K 30 Jun 2026 · at $91.40 · 1.5% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $56.76K 10 Jul 2026 · at $91.70 · 1.5% of stake Zovighian Bernard J CEO Sold at will $245.13K 27 Jul 2026 · at $83.93 · 24.7% of stake Markowitz Wayne CVP, JAPAC Sold at will $818.96K 28 Jul 2026 · at $85.06 · 30.8% of stake Markowitz Wayne CVP, JAPAC Sold at will $12.59K 30 Jul 2026 · at $86.03 · 0.7% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $56.97K 11 Aug 2026 · at $92.03 · 1.5% of stake Markowitz Wayne CVP, JAPAC Sold at will $113.42K 26 Aug 2026 · at $91.47 · 5.8% of stake Chopra Daveen CVP, TMTT, Surgical & IHFM Sold at will $2.89M 26 Aug 2026 · at $91.02 · 41.8% of stake Bruls Annette CVP, EMEACLA Sold at will $237.91K 28 Aug 2026 · at $89.98 · 12.8% of stake Dahl Andrew M. SVP, Corporate Controller Sold at will $49.53K 31 Aug 2026 · at $91.06 · 3.5% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $54.17K 11 Sep 2026 · at $87.51 · 1.5% of stake Lippis Daniel J. CVP, TAVR Sold on a plan $53.02K 8 Oct 2026 · at $85.65 · 1.5% of stake
0 buys19 sales at will25 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$6.07B
Net income
$1.07B
Free cash flow
$1.34B
Gross margin
78.0%
Operating margin
20.8%
Net margin
17.7%
Return on equity
10.4%
Return on capital
9.6%
Debt to equity
0.06
Revenue growth, 1 yr
11.6%
Revenue growth, 5 yr
6.7% a year
EPS growth, 1 yr
-73.7%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
4.4B 0K FY20 Fiscal year 2020 Revenue $4.39B Net income $0.00 Margin 0.0% 5.2B 1.5B FY21 Fiscal year 2021 Revenue $5.23B Net income $1.50B Margin 28.7% · growth +19.3% 4.5B 1.5B FY22 Fiscal year 2022 Revenue $4.46B Net income $1.52B Margin 34.1% · growth -14.7% 5B 1.4B FY23 Fiscal year 2023 Revenue $5.01B Net income $1.40B Margin 28.0% · growth +12.2% 5.4B 4.2B FY24 Fiscal year 2024 Revenue $5.44B Net income $4.17B Margin 76.7% · growth +8.6% 6.1B 1.1B FY25 Fiscal year 2025 Revenue $6.07B Net income $1.07B Margin 17.7% · growth +11.5%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
8 Oct 2026 Lippis Daniel J.
CVP, TAVR
Sold on a plan $53.02K 1.5%
11 Sep 2026 Lippis Daniel J.
CVP, TAVR
Sold on a plan $54.17K 1.5%
31 Aug 2026 Dahl Andrew M.
SVP, Corporate Controller
Sold at will $49.53K 3.5%
28 Aug 2026 Bruls Annette
CVP, EMEACLA
Sold at will $237.91K 12.8%
26 Aug 2026 Chopra Daveen
CVP, TMTT, Surgical & IHFM
Sold at will $2.89M 41.8%
26 Aug 2026 Markowitz Wayne
CVP, JAPAC
Sold at will $113.42K 5.8%